{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T21:45:45Z","timestamp":1794951945121,"version":"4.9.1"},"reference-count":0,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2003,11,14]],"date-time":"2003-11-14T00:00:00Z","timestamp":1068768000000},"content-version":"vor","delay-in-days":2327,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[1997,7]]},"abstract":"<jats:p> <jats:italic>Background<\/jats:italic>: Mucosal inflammation of the ileal pouch (pouchitis) is the major long\u2010term complication after ileal pouch\u2010anal anastomosis for ulcerative colitis. Broad\u2010spectrum antibiotics are the mainstay of treatment, however, 15% of patients with pouchitis have a chronic, treatment\u2010resistant disease.<\/jats:p><jats:p> <jats:italic>Aim<\/jats:italic>: To determine the safety and efficacy of bismuth carbomer enemas in achieving and maintaining remission in treatment\u2010resistant chronic pouchitis.<\/jats:p><jats:p> <jats:italic>Methods<\/jats:italic>: Twelve patients with treatment\u2010resistant chronic pouchitis were treated nightly for 45 days with enemas containing elemental bismuth complexed with carbomer. Diagnosis of pouchitis and response to treatment were evaluated with the Pouchitis Disease Activity Index (PDAI), which includes clinical, sigmoidoscopic and histological criteria. Serum bismuth concentrations were determined by atomic absorption.<\/jats:p><jats:p> <jats:italic>Results<\/jats:italic>: Ten of 12 patients (83%) went into remission, with a significant decrease of mean total PDAI score from 12 (range 9\u201315) to 6 (4\u201315) (<jats:italic>P\u2003<\/jats:italic>&lt;\u20030.002), and were continued on bismuth carbomer enemas administered every third night for 12 months. Patients were monitored clinically, sigmoidoscopically and histologically every 2 months for evidence of recurrence (increase \u2265\u20032 in the clinical symptom portion of the PDAI). Six of 10 patients (60%) were able to maintain remission throughout the 12\u2010month trial; 4\/10 had an exacerbation, two of which occurred soon after discontinuing daily treatment. Serum bismuth levels were negligible in all patients and no side\u2010effects were registered.<\/jats:p><jats:p> <jats:italic>Conclusions<\/jats:italic>: Our findings suggest that bismuth carbomer enemas are safe and effective in achieving and maintaining remission in patients with treatment\u2010resistant chronic pouchitis.<\/jats:p>","DOI":"10.1046\/j.1365-2036.1997.00217.x","type":"journal-article","created":{"date-parts":[[2003,11,14]],"date-time":"2003-11-14T11:43:13Z","timestamp":1068810193000},"page":"673-678","source":"Crossref","is-referenced-by-count":43,"title":["Long\u2010term efficacy of bismuth carbomer enemas in patients with treatment\u2010resistant chronic pouchitis"],"prefix":"10.1111","volume":"11","author":[{"given":"P.","family":"GIONCHETTI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"RIZZELLO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"VENTURI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"FERRETTI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"BRIGNOLA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"PERUZZO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"BELLOLI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"POGGIOLI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"MIGLIOLI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"CAMPIERI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,11,14]]},"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1997.00217.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.1997.00217.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T03:17:09Z","timestamp":1694402229000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.1997.00217.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,7]]}},"alternative-id":["10.1046\/j.1365-2036.1997.00217.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.1997.00217.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,7]]}}}